< Terug naar vorige pagina
Publicatie
Antibodies gone bad : the molecular mechanism of light chain amyloidosis
Tijdschriftbijdrage - Review Artikel
Light chain amyloidosis (AL) is a systemic disease in which abnormally proliferating plasma cells secrete large amounts of mutated antibody light chains (LCs) that eventually form fibrils. The fibrils are deposited in various organs, most often in the heart and kidney, and impair their function. The prognosis for patients diagnosed with AL is generally poor. The disease is set apart from other amyloidoses by the huge number of patient-specific mutations in the disease-causing and fibril-forming protein. The molecular mechanisms that drive the aggregation of mutated LCs into fibrils have been enigmatic, which hindered the development of efficient diagnostics and therapies. In this review, we summarize our current knowledge on AL amyloidosis and discuss open issues.
Tijdschrift: FEBS JOURNAL
ISSN: 1742-4658
Issue: 6
Volume: 290
Pagina's: 1398 - 1419
Jaar van publicatie:2023
Toegankelijkheid:Open